Clinical Genetics Research Program
Centre for Addiction and Mental Health
33 Russell St., Main Building, 1st floor
Toronto, ON M5S 2S1
(416) 535-8501 ext. firstname.lastname@example.org
Dr. Anne Bassett is Director of the Clinical Genetics Research Program in the Clinical Research Department and Clinician Scientist in the Campbell Family Mental Health Research Institute at CAMH. She is the Canada Research Chair in Schizophrenia Genetics and Genomics Disorders and a Professor of Psychiatry at the University of Toronto. Areas of Research
Dr. Bassett is an internationally renowned expert in the genetics of schizophrenia. She is the principal investigator of studies aiming to localize genes for schizophrenia and characterize genetic subtypes of schizophrenia. Her goal is to gain new insights into the mechanism of illness that should help develop new treatments. In research into familial schizophrenia, her group has localized regions of the genome likely to contain susceptibility genes for schizophrenia and has identified a candidate gene, NOS1AP, on chromosome 1. Dr. Bassett has also pioneered studies of an important but under-recognized subtype of schizophrenia known as 22q11.2 Deletion Syndrome that affects 1-2 of every 100 patients with schizophrenia. An exciting initiative involves translating research findings directly into clinical practice. Dr. Bassett's active career also includes teaching and public service, particularly for the Schizophrenia Society of Canada. Publications
View Dr. Bassett's publications on PubMed.